1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. FGFR
  4. FGFR Inhibitors

FGFR Inhibitors

FGFR

FGFR1

FGFR2

FGFR3

FGFR4

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

FGFR Inhibitors
Product Name FGFR FGFR1 FGFR2 FGFR3 FGFR4 Purity
Lenvatinib  
FGFR1, IC50: 46 nM
      99.74%
Nintedanib  
FGFR1, IC50: 69 nM
FGFR2, IC50: 37 nM
FGFR3, IC50: 108 nM
  99.97%
Ponatinib  
FGFR1, IC50: 2.2 nM
      99.13%
Infigratinib  
FGFR1, IC50: 0.9 nM
FGFR2, IC50: 1.4 nM
FGFR3, IC50: 1 nM
FGFR4, IC50: 60 nM
99.16%
AZD4547  
FGFR1, IC50: 0.2 nM
FGFR2, IC50: 2.5 nM
FGFR3, IC50: 1.8 nM
FGFR4, IC50: 165 nM
99.80%
FGFR4-IN-4        
FGFR4
ARQ 069  
unphosphorylated FGFR1, IC50: 0.84 μM
FGFR1 autophosphorylation, IC50: 2.8 μM
unphosphorylated FGFR2, IC50: 1.23 μM
FGFR2 autophosphorylation, IC50: 1.9 μM
   
Erdafitinib  
FGFR1, IC50: 1.2 nM
FGFR2, IC50: 2.5 nM
FGFR3, IC50: 3.0 nM
FGFR4, IC50: 5.7 nM
99.66%
SU 5402  
FGFR1, IC50: 30 nM
      99.39%
Pemigatinib  
FGFR1, IC50: 0.4 nM
FGFR2, IC50: 0.5 nM
FGFR3, IC50: 1.2 nM
FGFR4, IC50: 30 nM
98.95%
PD173074  
FGFR1, IC50: 25 nM
      99.55%
Gandotinib    
FGFR2, IC50: 32 nM
FGFR3, IC50: 106 nM
  99.96%
Fisogatinib        
FGFR4, IC50: 5 nM
99.84%
Nintedanib esylate  
FGFR1, IC50: 69 nM
FGFR2, IC50: 37 nM
FGFR3, IC50: 108 nM
  99.93%
Roblitinib        
FGFR4, IC50: 1.9 nM
99.33%
Lucitanib  
FGFR1, IC50: 17.5 nM
FGFR2, IC50: 82.5 nM
    99.32%
Futibatinib
FGFR
        98.80%
Rogaratinib  
FGFR1
FGFR2
FGFR3
FGFR4
99.38%
LY2874455  
FGFR1, IC50: 2.8 nM
FGFR2, IC50: 2.6 nM
FGFR3, IC50: 6.4 nM
FGFR4, IC50: 6 nM
98.02%
KW-2449  
FGFR1, IC50: 36 nM
      99.85%
PRN1371  
FGFR1, IC50: 0.6 nM
FGFR2, IC50: 1.3 nM
FGFR3, IC50: 4.1 nM
FGFR4, IC50: 19.3 nM
99.72%
Dovitinib  
FGFR1, IC50: 8 nM
 
FGFR3, IC50: 9 nM
  97.18%
BLU9931  
FGFR1, IC50: 591 nM
FGFR2, IC50: 493 nM
FGFR3, IC50: 150 nM
FGFR4, IC50: 3 nM
99.77%
CH5183284  
FGFR1, IC50: 9.3 nM
FGFR2, IC50: 7.6 nM
FGFR3, IC50: 22 nM
FGFR4, IC50: 290 nM
99.73%
Pazopanib Hydrochloride  
FGFR1, IC50: 140 nM
      99.83%
PD-166866  
FGFR1, IC50: 52.4 nM
      99.97%
Dovitinib lactate      
FGFR3, IC50: 5 nM
  99.96%
Sulfatinib  
FGFR1
      97.97%
Alofanib    
FGFR2
    99.83%
Derazantinib  
FGFR1, IC50: 4.5 nM
FGFR2, IC50: 1.8 nM
FGFR3, IC50: 4.5 nM
  99.06%
CP-547632
FGFR, IC50: 9 nM
        >99.0%
ENMD-2076  
FGFR1, IC50: 92.7 nM
FGFR2, IC50: 70.8 nM
    99.23%
FIIN-2  
FGFR1, IC50: 3.1 nM
FGFR2, IC50: 4.3 nM
FGFR3, IC50: 27 nM
FGFR4, IC50: 45 nM
99.95%
ENMD-2076 Tartrate  
FGFR1, IC50: 92.7 nM
FGFR2, IC50: 70.8 nM
    98.59%
Orantinib  
FGFR1, Ki: 1.2 μM
      98.80%
S49076  
FGFR1, IC50: 18 nM
FGFR1V561M, IC50: 23 nM
FGFR2, IC50: 17 nM
FGFR2N549H, IC50: 19 nM
FGFR3, IC50: 15 nM
  98.62%
EOC317  
FGFR1, IC50: 6 nM
      97.65%
ASP5878  
FGFR1, IC50: 0.47 nM
FGFR2, IC50: 0.6 nM
FGFR3, IC50: 0.74 nM
FGFR4, IC50: 3.5 nM
99.71%
SSR128129E  
FGFR1, IC50: 1.9 μM
      99.65%
Infigratinib phosphate  
FGFR1, IC50: 0.9 nM
FGFR2, IC50: 1.4 nM
FGFR3, IC50: 1 nM
FGFR4, IC50: 60 nM
97.74%
FIIN-3  
FGFR1, IC50: 13.1 nM
FGFR2, IC50: 21 nM
FGFR3, IC50: 31.4 nM
FGFR4, IC50: 35.3 nM
98.13%
CP-547632 hydrochloride
FGFR, IC50: 9 nM
        98.24%
FGFR4-IN-1        
FGFR4, IC50: 0.7 nM
99.88%
ODM-203  
FGFR1, IC50: 11 nM
FGFR2, IC50: 16 nM
FGFR3, IC50: 6 nM
FGFR4, IC50: 35 nM
99.33%
Tyrosine kinase-IN-1  
FGFR1, IC50: 2 nM
      99.47%
Lenvatinib mesylate  
FGFR1, IC50: 46 nM
     
PD-089828  
FGFR1, IC50: 0.15 μM
FGFR1, Ki: 0.14 μM
     
PD-161570  
FGFR1, IC50: 39.9 nM
FGFR1, Ki: 42 nM
FGFR1 autophosphorylation, IC50: 622 nM
     
Ponatinib D8  
FGFR1, IC50: 2.2 nM
     
SKLB610  
FGFR1
      99.23%
SSR128129E free acid  
FGFR1, IC50: 1.9 μM